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A B S T R A C T
Purpose: People with non-epileptic seizures (NES) consistently report poorer Health-Related Quality of
Life (HRQoL) than people with epilepsy. Yet, unlike in epilepsy, knowledge of how social factors inﬂuence
the HRQoL of adults with NES is limited. To add to the evidence base, this study explores the relationship
between HRQoL and perceived stigma among adults with NES, and the role of socio-demographic
characteristics.
Methods: Data was gathered from a survey of 115 people living with the condition, recruited from online
support groups. Participants provided socio-demographic and health-related data and completed a series
of questions investigating their HRQoL (QOLIE-31) and stigma perceptions (10-item Epilepsy Stigma
Scale).
Results: Participants were found to experience high levels of perceived stigma (median 5.2, mean 4.9). A
signiﬁcant and moderate inverse correlation was observed between HRQoL and stigma (rs 0.474,
p = < 0.001); suggesting higher perceptions of stigma contribute to poorer HRQoL among adults with
NES. Stigma perceptions were found to be most strongly associated with the seizure worry (rs =  0.479),
emotional wellbeing (rs =  0.421), and social functioning (rs = 0.407) HRQoL domains. Participants who
reported being in employment or education were found to have signiﬁcantly better HRQoL than those
who were not (p = < 0.001).
Conclusion: More (qualitative and quantitative) research is justiﬁed to understand how – and why – those
with the condition experience stigmatisation, and the factors that impede and help facilitate the
participation of people with NES in education and employment.
© 2018 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
There has been a marked shift in thinking about what health is
and how it is measured; with traditional clinical outcomes
increasingly giving way to, or used in conjunction with, patient
reported outcome measures (PROMs) [1]. Health related Quality of
Life (HRQoL), is a multidimensional PROM construct used to assess
the perceived impact of health status on quality of life; comprised
of physical functioning, emotional status, and social well-being
domains [2].
People with non-epileptic seizures (NES), often referred to as
psychogenic non-epileptic seizures (PNES) or non-epileptic attack
disorder (NEAD), consistently report poorer HRQoL than those
with epilepsy [3–5]. A recent systematic review of the literature
identiﬁed 14 studies arising from ten separate research projects
(data collections) that have explored associations between
independent factors and HRQoL in this patient group [6].
The evidence available suggests a strong adverse association
between psychological factors and the HRQoL of adults with NES.
Several studies show depression to be a strong predictor of poorer
HRQoL in this patient group [3–5,7–15]. Other psychological factors
associated with poorer HRQoL in people with NES include the
number/severity of mood and emotional complaints [3,9,14,15],
illness perceptions [16], dissociative experiences [8,11], somatic
symptoms [9,10,15], and escape-avoidance coping strategies [8,17].
Condition-related factors, such as older age of onset [15,18] and
experiencing the condition for a shorter period of time [15] have also
been shown to adversely affect HRQoL. As with epilepsy patient
groups [19], seizure freedom has been shown to be positively
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associated with HRQoL in patients with NES [20]. However, whereas
systematicreviews of the literaturehavefoundseizurefrequencytoa
(modest) predictor of HRQoL in adults with epilepsy [19], the same
was not found to be true for adults with NES [6].
Yet, as Mitchell and colleagues point out [11], studies that
attempt to produce a model to explain the factors that are
associated with HRQoL in adults with NES only account for 65% of
the variance at best [3]. Our limited understanding of how social
factors affect the HRQoL of those living with NES probably
contributes to this shortfall. There are signiﬁcant knowledge gaps
in relation to domains such as stigma, employment status, and
social and family relations [6].
HRQoL in this patient group has been negatively associated
with family roles and affective family involvement subscales using
the Family Assessment Device (FAD) [5], suggesting the roles and
inﬂuence of signiﬁcant others to be a potentially important
predictor of HRQoL for people with NES. There is also some
evidence that concerns about relationships with the main
caregiver seem to cause more distress in those with NES than
patients with epilepsy [21]. We know that the stigma associated
with epilepsy is considerable and that it has negative effects on
HRQoL [22] – in fact, it may account for more HRQoL variance than
clinical outcomes (such as seizure frequency and side-effects of
antiepileptic drugs) [23]. However, whereas there is a wealth of
research to support the view that the social prognosis of epilepsy is
often less good than the clinical one [22], comparatively little
research has explored the social impact of NES [24], and none has
explored the relationship between stigma and HRQoL in this
patient group to date. The only study to have examined the role of
socio-demographic variables found no signiﬁcant correlation
between employment status, marital status, having children,
religious involvement, and proximity to family and HRQoL [15], but
more research is needed to substantiate these ﬁndings.
To add to the evidence base, this study seeks to explore the
relationship between HRQoL and perceived stigma among adults
with NES, and the role of participants’ socio-demographic
characteristics. Findings (‘statistical pointers’) will inform an
upcoming qualitative study exploring the stigma perceptions of
people with the condition, which will include exploring partic-
ipants written texts about their family relations and the social
impact of NES. Taken together, we hope to identify social dynamics
that will contribute to larger (multiple regression) studies aiming
to produce a model to explain factors affecting the HRQoL of adults
with NES.
2. Methods
A link to an in-depth (86-item, 233-question) survey comprised
of polar, frequency, Likert scales, and open questions was
advertised to members of 20 patient and practitioner-led online
support groups and websites for people with NES (based in the UK
and US; not disclosed for reasons of conﬁdentiality, details
available on request). The survey was piloted among 25 people
living with the condition. Final survey data were organized around
four key themes: 1) the diagnostic journey 2) access to and
experience of treatment 3) interactions with healthcare profes-
sionals and 4) social support and social stigma. Advertising
commenced May 2016 and ﬁnal data collected from 1 July to 1
October 2016.
To include as many people with NES as possible, the only
inclusion criteria were that participants had to be over 18 years of
age and had received a diagnosis of NES by a health professional.
Participants were advised that we used the term NES throughout
the survey to describe diagnoses of psychogenic non-epileptic
seizures (PNES), non-epileptic attack disorder (NEAD), and other
diagnostic terms sometimes used to describe the condition and
symptoms; such as, dissociative, conversion, functional, and
pseudo seizures. They were also informed that we used the term
seizure throughout the survey, whilst recognising that some
people experience non-epileptic events in which they do not
exhibit movements, only brieﬂy lose consciousness, or experience
an altered state of consciousness, or a mixture of these behaviours
and sensations. Participants were advised that, unless otherwise
stated, to consider the term “seizure” to include such “events”.
Those with a dual-diagnosis of epilepsy and NES were asked to only
comment on non-epileptic seizures and events wherever possible.
Participants were able to save their answers and return to the
survey via a secure and automated email link. Typically, open (free-
text) questions were optional and all others mandatory. The smart-
logic survey format helped to protect against participants giving
conﬂicting answers, and to ‘re-check’ and correct responses when
they did so.
This study uses a subset of the full survey data to explore
associations between the socio-demographic and health-related
characteristics of participants, their HRQoL, and levels of perceived
stigmatisation; using the measures listed below.
2.1. Measures
Participants were asked a range of socio-demographic and
health-related questions, as indicated in Table 1.
The 31-item Quality of Life in Epilepsy inventory (QOLIE-31) [
25] was used to measure HRQoL. The inventory, designed for adults
with epilepsy aged 18 years and older, is divided into seven
subscales that explore various aspects of patients’ health and
wellbeing: emotional well-being, social functioning, energy/
fatigue, cognitive functioning, seizure worry, medication effects,
and overall quality of life (a single-item subscale). A weighted
average of the multi-item scale scores is used to obtain a total
score. Although speciﬁcally designed for people with epilepsy,
there are important clinical similarities and shared concerns
between NES and epilepsy patient populations. A review of health
status measures did not produce any better tools to assess the
construct of HRQoL in this patient population [26]; and a recent
systematic review identiﬁed the QOLIE-31 as the most popular
measure in studies exploring the HRQoL of this patient group [6].
Stigma was measured using the Epilepsy Stigma Scale devel-
oped by Dilorio and colleagues [27]. The ten-item scale assesses
the degree to which a person believes that their seizure condition
is perceived as negative and interferes with relationships with
others, rated on a 7-point scale from strongly disagree (1) to
strongly agree (7). Item responses are summed to yield a total
score. In this study, overall median scores (1–7) were calculated.
Higher scores are associated with greater perceptions of stigma. To
our knowledge, the measure has not been validated in a NES
patient population. We assessed the scale for internal consistency
and found a coefﬁcient for the responses of our (n = 115)
participants to be 0.89.
2.2. Statistical analysis
Analysis of the data was performed using SPSS, version 24. To
guard against assumptions of normality and homogeneity of
variance, and because measures include ordinal data, non-
parametric tests of signiﬁcance and correlation were used. In
some cases, mean scores are presented or discussed for compara-
tive purposes. The primary outcome measure was QOLIE-31
(weighted) total score. The Mann-Whitney U Test was used to
compare quantitative variables between two independent groups.
Spearman's rank correlation coefﬁcient (rs) was used to compare
continuous and ordinal data variables. The strength of correlations
were deﬁned as: 0–0.39 weak, 0.4–0.69 moderate, and 0.7–1
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strong. The coefﬁcient of determination (rs
2) was calculated to
establish the proportion of shared variance between HRQoL
domains and total stigma score. Holm’s Sequential Bonferroni
Procedure [28] was performed for multiple tests to protect against
inﬂation of Type 1 error. Statistically signiﬁcant results (p < 0.05)
not rejected following the Holm’s Sequential Bonferroni method
are shown in bold.
3. Results
3.1. Participants
289 people began the survey. Of these, 141 (49%) completed all
mandatory questions and submitted their responses for inclusion
in the study. Six people reported a diagnosis other than NES
(functional movement disorder) and their responses were
excluded from further analysis. Of the remaining 135 participants,
we report on 115 participants who described receiving “a formal
(highly likely or certain) diagnosis of NES” by a health professional.
20 participants who reported receiving “a tentative (possible or
likely) diagnosis of NES” (or who indicated they were awaiting
further tests) were excluded from further analysis.
The socio-demographic and health characteristics of the 115
participants included in this study are shown in Table 1.
3.2. Health-related quality of life
As a group, participants demonstrated a total median (weight-
ed) QOLIE-31 score of 31.7 (mean 33.8, 95%CI = 31.0–36.7). No
signiﬁcant differences in HRQoL (QOLIE-31 total scores) were
observed between those who self-reported a dual diagnosis of
epilepsy and NES (median 31.1, range 13.7–63.5), and those with
NES alone (median 31.7, range 3.4–87.8) (p = 0.800); nor were
signiﬁcant differences in individual HRQoL domain scores ob-
served between the two groups. No signiﬁcant associations were
found between HRQoL total scores and time from onset of NES
(rs =  0.111, p = 0.239) or time from onset to diagnosis (rs = 0.066,
p = 0.486). No signiﬁcant differences in HRQoL were observed
between those who had been erroneously diagnosed with epilepsy
in the past and those who had not (p = 0.502). Seizure frequency
was shown to be signiﬁcantly, but weakly correlated with HRQoL
(rs =  0.382, p = < 0.001). HRQoL was not signiﬁcantly correlated
with participants’ age (rs = 0.062, p = 0.512). Following the Holm–
Bonferroni method, participants in work or education reported
signiﬁcantly better HRQoL than those who were not. As shown in
Table 2, no other socio-demographic variables tested returned a
signiﬁcant result.
3.3. Stigma
The median stigma score across the whole group of participants
was 5.2 (mean 4.9, 95%CI = 4.7–5.2). No signiﬁcant differences in
perceived stigma (total stigma scores) were observed between
those who self-reported a dual diagnosis of epilepsy and NES
(median 5.2, range 2.7–7), and those with NES alone (median 5.2,
range 1–7) (p = 0.718). No signiﬁcant associations were found
between total stigma scores and time from onset of NES (rs = 0.070,
p = 0.456) or time from onset to diagnosis (rs = 0.049, p = 0.604). No
signiﬁcant differences in stigma scores were observed between
those who had been erroneously diagnosed with epilepsy in the
past and those who had not (p = 0.561). Seizure frequency was
shown to be signiﬁcantly, but weakly correlated with perceived
stigma scores (rs =  0.252, p = 0.007). After Holm-Bonferroni
correction, no signiﬁcant differences were observed between the
Table 1
Socio-demographic and health characteristics.
Number or median Proportion or range
Country UK (63) and Ireland (3) 66 57%
US (42) and Canada (2) 44 38%
Rest of the world (Australia and Norway) 5 4%
Age 37 years 18–75 years
Gender Female 102 89%
Male 11 10%
Transgender 2 2%
Relationship status Married/Civil Union (54) or partnered (17) 71 62%
Single (34) or separated or divorced (10) 44 38%
Living arrangements Living alone 13 11%
Living with others 102 89%
Employment status In full-time (14) or part-time employment
(14) or education (9)
37 32%
Unable to work (72) or home-maker (3) 75 65%
Retired 3 3%
Disability beneﬁts In receipt of disability beneﬁts 62 54%
Not in receipt of disability beneﬁts 53 46%
Time from onset (of NES) 4–5 years <1 year to 20+ years
Diagnosed by (multiple answers possible) A neurologist who specialises in seizures 81 70%
A neurologist who does not specialise in seizures 27 23%
A psychiatrist or clinical/neuro psychologist 28 24%
Time to diagnosis (of NES) 3–4 years <1 year to 20+ years
Tests used to diagnose NES (multiple answers
possible)
Electroencephalography (EEG) 96 83%
Ambulatory Electroencephalography (Amb-EEG) 23 20%
Video-Electroencephalography monitoring (vEEG) 60 52%
Electrocardiography (ECG or EKG) 69 60%
Magnetic resonance imaging (MRI) 88 77%
Computed Tomography (CT/CAT scan) 75 65%
Tilt table test 15 13%
Prior erroneous diagnosis of epilepsy Yes 28 24%
No 84 73%
Self-reported seizure diagnosis NES alone 100 87%
NES and Epilepsy 15 13%
NES frequency past month prior to testing 15 0-309
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stigma perceptions of socio-demographic groups detailed in
Table 2, nor was stigma signiﬁcantly correlated with participant
age (rs =  0.007, p = 0.942).
A signiﬁcant and moderate inverse correlation was found
between perceived stigma scale and HRQoL (QOLIE-31) total scores
(rs =  0.474, p < 0.001). As detailed in Table 3, analysis of QOLIE-31
subscales (post Holm–Bonferroni method) shows that seizure
worrya, emotional wellbeingb, social functioningc and stigma scale
scores were signiﬁcantly and moderately correlated; the propor-
tion of shared variance for these subscales was a23%, b18%, and
c17%. Energy/fatigue and cognitive subscales were found to be
signiﬁcantly, but weakly correlated with stigma. Medicat ion
effects and (the single-item) Overall QoL subscales were not found
to be signiﬁcantly correlated.
4. Discussion
This study sought to explore the relationship between social
factors (socio-demographic characteristics and stigma percep-
tions) and the HRQoL of adults with NES. Participants were found
to experience high levels of perceived stigma which was inversely
correlated with HRQoL. Stigma perceptions were most strongly
associated with the HRQoL domains seizure worry, emotional
wellbeing, and social functioning. HRQoL was better amongst
those in employment or education than those who were not.
The levels of perceived stigma reported by our participants
(mean 4.9) are considerably higher than typically found in epilepsy
patient populations. A study of 314 people with epilepsy using the
same measure reports a mean score of 3.7 [27]. Similarly, a recent
study using a single four-point Likert scale question taken from the
NEWQOL-6D (How much do you feel people treat you as an inferior
person?), found that perceived stigma was signiﬁcantly higher
among individuals with NES compared to those with epilepsy [29].
These ﬁndings ﬁt with the wider literature, which suggests that
people with functional somatic syndromes experience greater
perceived stigmatisation than those with comparable organic
disease [30].
The stigma of epilepsy is widely reported, and is consistently
linked to reduced HRQoL [22,31]. To our knowledge, ours is the ﬁrst
study to explore associations between HRQoL and stigma among
adults with NES. A signiﬁcant and moderate inverse correlation
was observed; suggesting higher perceptions of stigma contribute
to poorer HRQoL among those with the condition. Stigma
perceptions were found to be most strongly associated with
seizure worry, emotional wellbeing, and social functioning HRQoL
domains; with over one-half of the variability related to these
features. There is a dearth of research exploring the social stigma of
NES, but peripheral ﬁndings from previous studies broadly
corroborate our ﬁndings. Studies show that people with NES can
experience feelings of shame [32], blame and stigmatisation [
33,34]; and might conceal the condition and isolate themselves to
avoid potential adverse social reactions to seizures and feelings of
embarrassment [34,35]. On-going support from family, friends and
colleagues has been described extremely important in counter-
acting the social isolation associated with NES [36].
For people with NES, their stigma perceptions are probably not
without foundation. In Western nations derogatory views of NES
may be linked to the disparaging use of terms such as
‘psychosomatic’ in the media, which might be taken to mean an
illness that is feigned, malingered or representative of a character
ﬂaw [37]. Unfortunately, these pejorative opinions are also found
in medical circles [38]. For those with the condition, stigmatising
interactions with health professionals are not uncommon [39].
People with NES often report their symptoms are met with
disbelief, not taken seriously, and that the legitimacy of the illness
is sometimes questioned by clinicians [32,33,35,38–41]; and
research exploring health professionals’ views supports these
assessments [42–48].
Contrary to previous HRQoL ﬁndings [15], we found partic-
ipants who reported being in employment or education (part-time
or full-time) to have signiﬁcantly better HRQoL than those who
were not. This discrepancy might be explained the classiﬁcation of
those in education as ‘employed’ in our analysis. Before applying
the Holm–Bonferroni method, we also found receipt of disability
beneﬁts to be a differentiating factor. As previously observed [15],
we did not ﬁnd relationship status or participants’ age to be
discriminating factors. Nor were signiﬁcant differences observed
in relation to participants’ country of residence, gender, or living
arrangements and their HRQoL. To our knowledge, these are novel
ﬁndings and require substantiation.
Seizure frequency was shown to be signiﬁcantly, but weakly
correlated with HRQoL. This ﬁnding is in contrast to those of a
systematic review which concluded that seizure frequency is not a
predictor of HRQoL in this patient group [6]; but is consistent with
a study of 96 patients with NES, which found seizure frequency to
be signiﬁcantly associated with lower HRQoL summary scores (SF-
36) [10].
Participants’ socio-demographic characteristics were not found
to determine stigma perceptions. However, signiﬁcant differences
Table 3
Correlations between HRQoL (QOLIE-31) subscales and Stigma Scale scores.
QOLIE-31 subscale scores (weighted) rs p
Seizure worry 0.479 <0.001
Emotional wellbeing 0.421 <0.001
Social functioning 0.407 <0.001
Cognitive 0.314 0.001
Energy and fatigue 0.252 0.007
Medication effects -0.146 0.120
Overall QoL -0.132 0.161
Table 2
Differences in HRQoL and Stigma between socio-demographic groups.
QOLIE-31 total score Stigma Scale total score
Grouping variable Groups Median (and range) Sig. Median (and range) Sig.
Countries UK and Ireland 33.3 (13.4–87.8) 0.534 5.1 (1.3–7.0) 0.250
US and Canada 30.6 (3.4–60.2) 5.3 (1.0–7.0)
Gender Male 32.0 (11.7–57.0) 0.532 5.0 (3.6–6.4) 0.934
Female 31.7 (3.4–87.2) 5.2 (1.0–7.0)
Relationship status Single, separated, divorced 32.5 (12.6–87.8) 0.929 5.5 (1.3–7.0) 0.022
Married, Civil Union, partnered 31.1 (3.4–66.5) 5.0 (1.0–6.8)
Living arrangements Living alone 39.3 (15.7–87.8) 0.126 5.5 (1.3–6.5) 0.463
Living with others 30.4 (3.4–66.5) 5.2 (1.0–7.0)
Employment status Not in work or education 28.0 (3.4–66.5) <0.001 5.3 (1.0–7.0) 0.017
In work or education 41.5 (22.2–87.8) 4.8 (1.3–6.6)
Disability beneﬁts In receipt 29.6 (9.7–66.5) 0.025 5.3 (1.7–7.0) 0.057
Not in receipt 37.9 (3.4–87.8) 4.9 (1.0–6.5)
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in levels of felt stigma according to relationship and employment
status were noted prior to applying the Holm–Bonferroni method;
and seizure frequency was shown to be signiﬁcantly (albeit
weakly) correlated with perceived stigma scores. These ﬁndings
are consistent with studies of epilepsy patient populations [27,49],
but require veriﬁcation in NES patient populations.
4.1. Limitations
While our ﬁndings offer a novel contribution to the literature, it
is important that they are interpreted within the context of their
limitations.
Perhaps the greatest concern with the collection of internet-
based patient information is the reliability and validity of the data
obtained. Yet, recent reviews suggest health data can be collected
with equal or even better reliability in Web-based questionnaires
compared with traditional approaches [50]. Participants were able
to complete the survey over an extended period if they so wished,
and survey metrics show that 97% of respondents completed the
survey within 82 h (around 3.5 days). The added beneﬁt of time for
reﬂection, the ability to consider and correct information, and the
use of validation checks (as used in our survey) has been shown to
improve data quality [50]. There are also strong indications that
web-based questionnaires are less prone to social desirability bias [
50,51]. Studies show that perceived health status data [52] and
HRQoL measures [53] can be reliably collected using online
methods. However, it is important to note that the standardised
measures used in this study have not been tested in internet-based
studies, and research is needed to conﬁrm their online reliability.
Due to the design of our study, there is no way to assess response
rate. Using number of surveys started as a proxy denominator
suggests a completion rate of 49%.
Previous studies exploring the HRQoL of adults with NES have
recruited participants from inpatient epilepsy monitoring units
(EMUs), outpatient neurology settings, psychotherapeutic centres,
or a combination of these; and most report diagnoses were
established using video-electroencephalography monitoring (vid-
eo-EEG) [6]. Video-EEG is the best-practice (‘gold standard’)
diagnostic method [54]; however, it is expensive and resource
limited [55] and may not be feasible because of the low frequency
of seizures [56].
Of the participants in this study only half describe undergoing
video-EEG monitoring, with the remainder reporting electroen-
cephalography (EEG) or ambulatory-electroencephalography
(Amb-EEG) testing. Our approach means that we cannot say to
what extent participants met the diagnostic criteria for NES
proposed by the PNES Task Force of the International League
Against Epilepsy Non-epileptic Seizures Task Force guidelines [
54,57]. We must also consider that the diagnosis of NES is
notoriously complex and difﬁcult, and some participants may have
been misdiagnosed. In view of the uncertainties about the
diagnosis inherent in our recruitment method, the inclusion of
people with a dual diagnosis of epilepsy and NES (13% of the
sample) could also be considered a limitation of this study.
However, given that this study was intended to explore the
sociological dimension of NES, we thought it was important not to
exclude any subgroup of the whole NES patient population.
Epilepsy is an important comorbidity of NES and the 13% ﬁgure
actually places our study well within the prevalence range of
comorbid epilepsy which has previously been reported in HRQoL
studies of NES patient populations (6–22%) [9,11,20]. Participants
with mixed seizure disorders were encouraged to think about their
NES when responding to questions about their seizures, but we
acknowledge that we cannot be certain that all respondents were
able to distinguish accurately between their epileptic and non-
epileptic seizures.
Despite differences in recruitment methods, other socio-
demographic and health-related characteristics of our participants
are also within the range of those reported in previous studies
exploring the HRQoL of people with NES. In terms of age and
gender (mean 31–42 years, 69–100% female) [6]; relationship
status (58% married or partnered) [4,9]; proportion in education or
employment (45–67%) [4,8]; time from onset of NES (median 3–4
years) [10,13] (mean 4.7–8.9 years) [3,5,8,18]; time to diagnosis of
NES (median 3.5 years) [11]; and frequency of NES in the four
weeks prior to testing (median 6–15 seizures) [4,5,10] mean (10.9
to 23.7) [3,12,20]. Data pertaining to physical and psychological
comorbidities was not within the scope of our analysis, and our
sample might differ from those previously described in these
respects.
There might also be important differences between people with
NES who have access to the Internet and participate in patient
support groups, and those who do not. It is also a weakness of the
study that the recruitment method did not allow us to recruit a
comparison group, and the study is cross-sectional and correla-
tional, which means that results can be bidirectional and should be
interpreted with caution. It is possible that changes in social
circumstances or status are more relevant to HRQoL and/or stigma
than current circumstances – something best explored longitudi-
nally. The correlational nature of our ﬁndings means that we
cannot say anything about causalities.
5. Conclusion
Despite these limitations, the research improves our under-
standing of how social factors and dynamics might inﬂuence the
HRQoL of adults with NES. To our knowledge, the study is the
largest HRQoL survey of people with NES to date, and the ﬁrst to
explore the relationship between HRQoL and stigma in this patient
group. An important ﬁnding is that participants experience high
levels of perceived stigma, which negatively affects their HRQoL.
Our data suggests that not being in employment or education is
detrimental to the HRQoL of people with NES.
These exploratory ﬁndings serve a heuristic function, in that
they identify several issues for further (qualitative) research.
Qualitative analysis can help achieve fuller and more complete
descriptions of phenomena, help correct interpretation of quanti-
tative results, and provide triangulation [58]. Perceived stigma
could be a treatment target, and research is needed to understand
how – and why – those with the condition experience stigmatisa-
tion; which in our data was most strongly associated with seizure
worry, emotional wellbeing, and social functioning HRQoL
domains. More research is also needed to understand factors that
impede and help facilitate the participation of people with NES in
education and employment. These studies could be usefully
followed-up by a project that looks speciﬁcally at the enacted
stigma faced by this patient group.
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